These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21385138)

  • 1. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.
    Suk JS; Lai SK; Boylan NJ; Dawson MR; Boyle MP; Hanes J
    Nanomedicine (Lond); 2011 Feb; 6(2):365-75. PubMed ID: 21385138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.
    Suk JS; Boylan NJ; Trehan K; Tang BC; Schneider CS; Lin JM; Boyle MP; Zeitlin PL; Lai SK; Cooper MJ; Hanes J
    Mol Ther; 2011 Nov; 19(11):1981-9. PubMed ID: 21829177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.
    Suk JS; Lai SK; Wang YY; Ensign LM; Zeitlin PL; Boyle MP; Hanes J
    Biomaterials; 2009 May; 30(13):2591-7. PubMed ID: 19176245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
    Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.
    Hida K; Lai SK; Suk JS; Won SY; Boyle MP; Hanes J
    PLoS One; 2011; 6(5):e19919. PubMed ID: 21637751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.
    Yang M; Lai SK; Yu T; Wang YY; Happe C; Zhong W; Zhang M; Anonuevo A; Fridley C; Hung A; Fu J; Hanes J
    J Control Release; 2014 Oct; 192():202-8. PubMed ID: 25090196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery.
    Chai G; Hassan A; Meng T; Lou L; Ma J; Simmers R; Zhou L; Rubin BK; Zhou QT; Longest PW; Hindle M; Xu Q
    Nanomedicine; 2020 Oct; 29():102262. PubMed ID: 32623017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.
    Broughton-Head VJ; Smith JR; Shur J; Shute JK
    Pulm Pharmacol Ther; 2007; 20(6):708-17. PubMed ID: 17055310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls.
    Nafee N; Forier K; Braeckmans K; Schneider M
    Eur J Pharm Biopharm; 2018 Mar; 124():125-137. PubMed ID: 29291931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.
    Lai SK; Suk JS; Pace A; Wang YY; Yang M; Mert O; Chen J; Kim J; Hanes J
    Biomaterials; 2011 Sep; 32(26):6285-90. PubMed ID: 21665271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.
    Lai SK; O'Hanlon DE; Harrold S; Man ST; Wang YY; Cone R; Hanes J
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1482-7. PubMed ID: 17244708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport.
    Dawson M; Wirtz D; Hanes J
    J Biol Chem; 2003 Dec; 278(50):50393-401. PubMed ID: 13679362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy.
    Forier K; Messiaen AS; Raemdonck K; Deschout H; Rejman J; De Baets F; Nelis H; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    Nanomedicine (Lond); 2013 Jun; 8(6):935-49. PubMed ID: 23035662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
    Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
    Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery.
    Leal J; Peng X; Liu X; Arasappan D; Wylie DC; Schwartz SH; Fullmer JJ; McWilliams BC; Smyth HDC; Ghosh D
    J Control Release; 2020 Jun; 322():457-469. PubMed ID: 32243979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors.
    Schuster BS; Kim AJ; Kays JC; Kanzawa MM; Guggino WB; Boyle MP; Rowe SM; Muzyczka N; Suk JS; Hanes J
    Mol Ther; 2014 Aug; 22(8):1484-1493. PubMed ID: 24869933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylation for enhancing nanoparticle diffusion in mucus.
    Huckaby JT; Lai SK
    Adv Drug Deliv Rev; 2018 Jan; 124():125-139. PubMed ID: 28882703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
    Addante A; Raymond W; Gitlin I; Charbit A; Orain X; Scheffler AW; Kuppe A; Duerr J; Daniltchenko M; Drescher M; Graeber SY; Healy AM; Oscarson S; Fahy JV; Mall MA
    Eur Respir J; 2023 May; 61(5):. PubMed ID: 37080569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
    Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
    Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
    Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
    J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.